Merck & Co Inc
Medicare will allow pharmaceutical companies to publicly discuss drug price negotiations
Hundreds of 1199SEIU health care workers staged a rally and sit to block 3rd avenue where some were arrested. They protested against health care cuts in Governor Kathy Hochuls budget on Medicare. Lev Radin | Lightrocket | Getty Images Medicare on Friday said it will allow pharmaceutical companies to publicly discuss the program’s historic drug […]
Read More
Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations
Traders work on the floor of the New York Stock Exchange during morning trading, April 10, 2023. Michael M. Santiago | Getty Images The pharmaceutical industry’s largest lobbying group and two other organizations on Wednesday sued the Biden Administration over Medicare’s new powers to slash drug prices for seniors under the Inflation Reduction Act. Pharmaceutical […]
Read More
Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court
Chief Executive Officers of pharmaceutical companies testify before the Senate Finance Committee on “Drug Pricing in America: A Prescription for Change, Part II” February 26, 2019 in Washington, DC. From left to right are Richard A. Gonzalez, chairman and CEO of AbbVie Inc; Pascal Soriot, executive director and CEO of AstraZeneca; Giovanni Caforio, chairman of […]
Read More
Inventory futures are flat soon after S&P 500 notches best near considering the fact that August: Stay updates
A trader is effective on the flooring of the New York Stock Trade (NYSE) in New York Metropolis, U.S., May possibly 30, 2023. Brendan McDermid | Reuters Shares futures had been flat in overnight investing after the S&P 500 notched its highest closing stage of 2023. The tail-end of earnings year pressed on with benefits […]
Read More
Merck sues Biden administration over Medicare drug price negotiations
Jakub Porzycki | NurPhoto | Getty Images Global drugmaker Merck on Tuesday sued the Biden administration over Medicare’s new powers to substantially reduce drug prices for seniors under the Inflation Reduction Act, the opening salvo in the pharmaceutical industry’s efforts to weaken the program. In a scathing complaint filed in federal district court, Merck excoriated […]
Read More
Moderna cancer vaccine used with Merck Keytruda reduces risk of deadly skin cancer spreading
Asbe | Istock | Getty Images Moderna‘s experimental cancer vaccine, used in combination with Merck‘s Keytruda, reduced the risk of the most deadly form of skin cancer spreading to other parts of the body in a clinical trial, according to the midstage trial results published on Monday. Moderna’s cancer vaccine reduced the risk of melanoma […]
Read More
Goldman unveils a new listing of its top inventory picks for consumers. Here’s what’s on it
Goldman Sachs produced its list of substantial-conviction shares — with a new twist. The business sourced buy-rated stocks from its U.S. investigation analysts. What makes this checklist exclusive from the regular top picks list is users of Goldman’s Investment decision Overview Committee ended up the kinds picking out the names, introducing a second layer of […]
Read More
ASCO conference will put the focus on the fight against cancer. These stocks are in the spotlight
Developments in cancer research will be in the spotlight as the American Society of Clinical Oncology hosts the world’s biggest cancer research conference in Chicago, starting Thursday. Investors have already caught a glimpse of the topics that will be discussed but many are eager to hear the details behind the abstracts, and no doubt there […]
Read More
Pfizer to raise $31 billion in debt offering to fund Seagen acquisition, SEC filing shows
A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange, July 29, 2019. Brendan McDermid | Reuters Pfizer plans to raise $31 billion through a debt offering to fund its proposed acquisition of cancer drugmaker Seagen, for what would be its largest takeover since 2009, according to […]
Read More
GOP law cut Big Pharma tax rates by 40%, Senate report says
(L-R) Richard A. Gonzalez, chairman and CEO of AbbVie Inc., Pascal Soriot, executive director and CEO of AstraZeneca, Giovanni Caforio, chairman of the board and CEO of Bristol-Myers Squibb Co., Jennifer Taubert, executive vice president and worldwide chairman of Janssen Pharmaceuticals, Johnson & Johnson, Kenneth C. Frazier, chairman and CEO of Merck & Co. Inc., […]
Read More